Company name:

Alarmcom Holdings Inc

  • IPO SHARE PRICE:
    $14.00
  • IPO DATE:
    June 26, 2015
  • TICKER:
    ALRM
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    8281 Greensboro Drive Suite 100 Tysons Virginia 22102
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

Alarmcom Holdings Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Statement of Cash Flow

Quarterly Annual
(USD in thousand)
Selected Year:
31-Dec
2020
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
45.7% - Net income (loss)
17.4% - Stock-based compensation
16.4% - Depreciation and amortization
8.2% - Accounts payable accrued expenses and other liabilities
5.3% - Amortization of operating leases
2.0% - Acquired in-process research and development
1.3% - Provision for credit losses on accounts receivable
1.2% - Deferred revenue
1.1% - Reserve for product returns
0.9% - Provision for excess and obsolete inventory
0.5% - Amortization of patents and tooling
0.1% - Amortization of debt issuance costs
SOURCEs
5.3% 16.4% 8.2% 17.4% 45.7%
100 %
0%
USES
60.9% 6.0% 6.1% 6.3% 14.7%
14.7% - Gain on sale of investments
6.3% - Inventory
6.1% - Operating lease liabilities
6.0% - Accounts receivable
1.9% - Deferred income taxes
1.6% - Other assets
1.5% - Change in fair value of contingent liability
0.4% - (Gain) loss on investments
0.3% - Other liabilities
0.2% - Provision for (recovery of) credit losses on notes receivable
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
$45,679
 $21,524 $53,330 $76,660 $76,660 $62,556
Depreciation and amortization
$45,679
$45,679
$45,679
$45,679
$45,679
 21,721 22,134 27,520 27,520 29,988
Amortization of operating leases
-
-
-
-
$45,679
 - 7,600 8,888 8,888 9,304
Amortization on patents
$45,679
-
-
-
-
 - - - - -
Amortization of patents and tooling
-
$45,679
$45,679
$45,679
$45,679
 900 700 882 882 1,112
Amortization of debt issuance costs
$45,679
$45,679
$45,679
$45,679
$45,679
 108 108 108 108 108
Stock-based compensation
$45,679
$45,679
$45,679
$45,679
$45,679
 13,429 20,603 29,176 29,176 33,100
(Recovery of) provision for doubtful accounts
$45,679
$45,679
$45,679
$45,679
$45,679
 149 1,170 - - -
Provision for credit losses on accounts receivable
-
-
-
-
-
 - 1,170 2,162 2,162 8,648
Provision for excess and obsolete inventory
-
-
-
-
-
 - 485 1,451 1,451 1,092
Provision for notes receivable
-
-
-
$45,679
$45,679
 3,319 (3,272) - - -
Provision for (recovery of) credit losses on notes receivable Provision for (recovery of) credit losses on notes receivable
-
-
-
-
-
 - (3,272) (359) (359) (1,436)
Deferred income taxes
$45,679
$45,679
$45,679
$45,679
$45,679
 (11,482) 2,599 (3,256) (3,256) (7,104)
(Income) loss from equity method investments
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - - -
Loss on goodwill and intangible assets impairment
$45,679
-
-
-
-
 - - - - -
Disposal of property and equipment
-
-
$45,679
$45,679
$45,679
 1,410 - - - -
Gain on release of contingent liability
$45,679
-
-
-
-
 - - - - -
Impairment of cost method investment
$45,679
$45,679
-
-
-
 - - - - -
Impairment of investment
-
-
-
-
$45,679
 - 605 - - -
(Gain) loss on investments
-
-
-
-
-
 - 605 (676) (676) (2,704)
Gain on sale of investments
-
-
-
-
-
 - - (24,737) (24,737) -
Loss (gain) on notes receivable
-
-
-
-
$45,679
 - (6,931) - - -
Change in fair value of contingent liability
$45,679
$45,679
$45,679
$45,679
$45,679
 - (198) (2,595) (2,595) (8)
Acquired in-process research and development
-
-
-
-
$45,679
 - 850 3,297 3,297 -
Reserve for product returns
$45,679
$45,679
$45,679
$45,679
$45,679
 273 (123) 1,795 1,795 1,216
Accounts receivable
$45,679
$45,679
$45,679
$45,679
$45,679
 (9,298) (22,273) (10,098) (10,098) (11,868)
Inventory
$45,679
$45,679
$45,679
$45,679
$45,679
 (8,813) (6,491) (10,647) (10,647) (13,752)
Other assets
$45,679
$45,679
$45,679
$45,679
$45,679
 115 (2,887) (2,683) (2,683) 11,464
Accounts payable accrued expenses and other liabilities Accounts payable accrued expenses and other liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 30,615 (10,980) 13,781 13,781 31,536
Deferred revenue
$45,679
$45,679
$45,679
$45,679
$45,679
 (1,502) (1,567) 2,031 2,031 (1,372)
Operating lease liabilities
-
-
-
-
$45,679
 - (8,268) (10,177) (10,177) (11,000)
Other
$45,679
$45,679
-
-
-
 - - - - -
Other liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
 (1,758) 403 (443) (443) (1,660)
Net cash provided by (used in) operating activities
$45,679
$45,679
$45,679
$45,679
$45,679
 $60,710 $47,112 $102,080 $102,080 $141,640
Selected Year:
31-Dec
2020
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
53.5% - Sale of investment securities
4.2% - Receipt of payment on notes receivable
SOURCEs
42.2% 53.5% 4.2%
100 %
0%
USES
33.6% 6.9% 54.8%
54.8% - Acquisition of business net of cash
33.6% - (Purchase) sale of property and equipment
6.9% - Purchases of in-process research and development
2.5% - Issuances or purchases of notes receivable
2.2% - Purchases of patents and patent licenses
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
(Purchases) sales of marketable securities
$45,679
$45,679
-
-
-
 - - - - -
Sale of investment securities
-
-
-
-
-
 - - 25,687 25,687 -
(Purchase) sale of property and equipment
$45,679
$45,679
$45,679
$45,679
$45,679
 (11,015) (19,324) (16,141) (16,141) (21,856)
Purchases of in-process research and development
-
-
-
-
$45,679
 - (850) (3,297) (3,297) -
Purchases of licenses to patents
$45,679
$45,679
$45,679
-
-
 - - - - -
Purchases of patents and patent licenses
-
-
-
$45,679
$45,679
 (1,075) - (1,050) (1,050) (600)
Issuances or purchases of notes receivable
$45,679
$45,679
$45,679
$45,679
$45,679
 (1,287) (26,103) (1,200) (1,200) (2,400)
Receipt of payment on notes receivable
-
-
$45,679
$45,679
$45,679
 - 31,696 2,026 2,026 12
Repayments of notes receivable
-
$45,679
-
-
-
 - - - - -
Acquisition of business net of cash
$45,679
$45,679
$45,679
$45,679
$45,679
 - (58,833) (26,299) (26,299) (105,196)
Investment in cost and equity method investees
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - - -
Distribution from cost method investee
$45,679
$45,679
-
-
-
 - - - - -
Net cash provided by (used in) investing activities
$45,679
$45,679
$45,679
$45,679
$45,679
 ($13,377) ($73,414) ($20,274) ($20,274) ($130,040)
Selected Year:
31-Dec
2020
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
81.0% - Borrowing under Revolving Credit Facility
19.0% - Issuance of common stock under Employee Stock Purchase Plan (ESPP)
SOURCEs
81.0% 19.0%
100 %
0%
USES
84.3% 4.9% 8.3%
8.3% - Repurchases of common stock
4.9% - Repayment of Revolving Credit Facility
2.5% - Business acquisition deferred consideration payment
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Initial Public Offering (IPO) net
$45,679
-
$45,679
-
-
 - - - - -
Issuance of common stock under Employee Stock Purchase Plan (ESPP) Issuance of common stock under Employee Stock Purchase Plan (ESPP)
$45,679
$45,679
$45,679
$45,679
$45,679
 6,400 3,870 11,711 11,711 20,408
Proceeds from issuance of common stock upon early exercise of stock options Proceeds from issuance of common stock upon early exercise of stock options
$45,679
$45,679
$45,679
-
-
 - - - - -
Offering costs
$45,679
$45,679
$45,679
-
-
 - - - - -
Borrowing under Revolving Credit Facility
-
-
$45,679
-
$45,679
 - - 50,000 50,000 -
Repayment of Revolving Credit Facility
-
-
$45,679
$45,679
$45,679
 (4,000) (4,000) (3,000) (3,000) (4,000)
Repayment of Term Loan
$45,679
$45,679
-
-
-
 - - - - -
Borrowing
-
$45,679
-
-
-
 - - - - -
Debt issuance costs
-
$45,679
$45,679
$45,679
$45,679
 - - - - -
Business acquisition deferred consideration payment
-
-
-
-
-
 - - (1,538) (1,538) (2,876)
Payments for long-term business acquisition liabilities Payments for long-term business acquisition liabilities
-
$45,679
-
-
-
 - - - - -
Payments of long-term consideration from business acquisitions Payments of long-term consideration from business acquisitions
-
-
$45,679
$45,679
-
 - - - - -
Tax benefit from stock-based compensation
$45,679
$45,679
-
-
-
 - - - - -
Dividends paid
$45,679
-
$45,679
-
-
 - - - - -
Dividends paid to employees for unvested shares
$45,679
-
$45,679
-
-
 - - - - -
Dividends on redeemable convertible preferred stock
$45,679
-
$45,679
-
-
 - - - - -
Repurchases of common stock
$45,679
$45,679
$45,679
$45,679
$45,679
 (1) - (5,149) (5,149) (20,596)
Net cash provided by (used in) financing activities
$45,679
$45,679
$45,679
$45,679
$45,679
 $2,399 ($130) $52,024 $52,024 $13,532
Selected Year:
31-Dec
2020
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$133,830,000
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cash and equivalents - Beginning of period
$45,679
$45,679
$45,679
$45,679
$45,679
 $96,329 $146,061 $119,629 - $988,704
(Decrease) increase in cash and cash equivalents
$45,679
$45,679
$45,679
$45,679
$45,679
 49,732 (26,432) 133,830 - 25,132
Cash and equivalents - End of period
$45,679
$45,679
$45,679
$45,679
$45,679
 $146,061 $119,629 $253,459 - $1,013,836